• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Respiratory disorder biotech Upstream Bio files for a $100 million IPO

cafead

Administrator
Staff member
  • cafead   Sep 18, 2024 at 11:22: PM
via Upstream Bio, a clinical-stage biotech developing a monoclonal antibody to target respiratory disorders, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering.

article source
 

<